He said studies have shown that there was a possibility that a third dose would be needed next year.
“This is also one of the strategies to deal with (virus) variants should that happen,” he said.
An endemic is medically defined as a disease outbreak within a geographic location that exists perpetually.
“We can ask the companies selling (vaccines) to us to provide new vaccine formulae so that we can deal with mutated variants,” he told a media conference after receiving the Sinovac vaccine shot at Rembau Hospital today.
Khairy, who is also science, technology and innovation minister, was asked what the government’s plans were should there be an over purchase of Covid-19 vaccines.
Khairy said if there was a surplus, the vaccines would be kept as buffer stock for a number of reasons.
“Right now, we are going through a phase of clinical trials on teenagers aged 12 to 18. If it is found that this vaccine is safe for that group, then we will involve teenagers in this immunisation program. That is why we need a buffer stock,” he said.
Meanwhile, Khairy explained that the National Pharmaceutical Regulatory Division’s (NPRA) application to Pfizer for its vaccine was for two doses.
“We can’t change it to a single dose according to our whims and fancies as clinical data show that the best immunisation is only with two doses.”
Meanwhile, Khairy once again gave his assurance that the Sinovac vaccine was safe, saying that it had been evaluated by the NPRA and found to have the same safety level as the Pfizer BioNtech vaccine.
He said Sinovac has also been used worldwide, and to date, more than 60 million doses have been administered and had also received 27 Emergency Use Authorisations globally, including in China, Indonesia, Turkey and Brazil.
On another matter, he said the government hopes to negotiate terms of a vaccine passport with China in the near future.
He said he was also in talks with Singapore on mutual recognition, and hoped to do the same with China.
CLICK HERE FOR THE LATEST DATA ON THE COVID-19 SITUATION IN MALAYSIA